173 related articles for article (PubMed ID: 18301056)
1. Immune activation and AIDS pathogenesis.
Sodora DL; Silvestri G
AIDS; 2008 Feb; 22(4):439-46. PubMed ID: 18301056
[No Abstract] [Full Text] [Related]
2. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.
Doitsh G; Galloway NL; Geng X; Yang Z; Monroe KM; Zepeda O; Hunt PW; Hatano H; Sowinski S; Muñoz-Arias I; Greene WC
Nature; 2014 Jan; 505(7484):509-14. PubMed ID: 24356306
[TBL] [Abstract][Full Text] [Related]
3. Redefining the viral reservoirs that prevent HIV-1 eradication.
Eisele E; Siliciano RF
Immunity; 2012 Sep; 37(3):377-88. PubMed ID: 22999944
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus resistance to nucleos(t)ide analogues.
Zoulim F; Locarnini S
Gastroenterology; 2009 Nov; 137(5):1593-608.e1-2. PubMed ID: 19737565
[TBL] [Abstract][Full Text] [Related]
5. A Perfect Storm: The Convergence of Aging, Human Immunodeficiency Virus Infection, and Inflammasome Dysregulation.
Thirugnanam S; Rout N
Curr Issues Mol Biol; 2024 May; 46(5):4768-4786. PubMed ID: 38785555
[TBL] [Abstract][Full Text] [Related]
6. T cell activation is insufficient to drive SIV disease progression.
Apetrei C; Gaufin T; Brocca-Cofano E; Sivanandham R; Sette P; He T; Sivanandham S; Martinez Sosa N; Martin KJ; Raehtz KD; Kleinman AJ; Valentine A; Krampe N; Gautam R; Lackner AA; Landay AL; Ribeiro RM; Pandrea I
JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37485874
[TBL] [Abstract][Full Text] [Related]
7. Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles.
Moyano A; Ndlovu B; Mbele M; Naidoo K; Khan N; Mann JK; Ndung'u T
PLoS One; 2023; 18(6):e0286507. PubMed ID: 37267224
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.
Hsu J; Van Besien K; Glesby MJ; Pahwa S; Coletti A; Warshaw MG; Petz L; Moore TB; Chen YH; Pallikkuth S; Dhummakupt A; Cortado R; Golner A; Bone F; Baldo M; Riches M; Mellors JW; Tobin NH; Browning R; Persaud D; Bryson Y;
Cell; 2023 Mar; 186(6):1115-1126.e8. PubMed ID: 36931242
[TBL] [Abstract][Full Text] [Related]
9. HTLV-1 Coinfection among Patients Attending a Large HIV Treatment Centre in Trinidad.
Edwards RJ; Julien-Serrette K; Edwards J; Boyce G
Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36363801
[TBL] [Abstract][Full Text] [Related]
10. Control of Simian Immunodeficiency Virus Infection in Prophylactically Vaccinated, Antiretroviral Treatment-Naive Macaques Is Required for the Most Efficacious CD8 T Cell Response during Treatment with the Interleukin-15 Superagonist N-803.
Ellis-Connell AL; Balgeman AJ; Harwood OE; Moriarty RV; Safrit JT; Weiler AM; Friedrich TC; O'Connor SL
J Virol; 2022 Oct; 96(20):e0118522. PubMed ID: 36190241
[TBL] [Abstract][Full Text] [Related]
11. Short- and long-term effects of antiretroviral therapy on peripheral regulatory CD4+/CD25hi/CD127low T lymphocytes in people living with HIV/AIDS.
Hu R; Chen T; Yan Y; Zhou Y; Yang R; Xiong Y
Rev Inst Med Trop Sao Paulo; 2022; 64():e11. PubMed ID: 35170712
[TBL] [Abstract][Full Text] [Related]
12. So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.
Kleinman AJ; Pandrea I; Apetrei C
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062339
[TBL] [Abstract][Full Text] [Related]
13. Pre-existing Simian Immunodeficiency Virus Infection Increases Expression of T Cell Markers Associated with Activation during Early
Larson EC; Ellis-Connell A; Rodgers MA; Balgeman AJ; Moriarty RV; Ameel CL; Baranowski TM; Tomko JA; Causgrove CM; Maiello P; O'Connor SL; Scanga CA
J Immunol; 2021 Jul; 207(1):175-188. PubMed ID: 34145063
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy.
Terahara K; Iwabuchi R; Tsunetsugu-Yokota Y
Viruses; 2021 Apr; 13(5):. PubMed ID: 33924786
[TBL] [Abstract][Full Text] [Related]
15. Differential recognition of HIV-stimulated IL-1β and IL-18 secretion through NLR and NAIP signalling in monocyte-derived macrophages.
Triantafilou K; Ward CJK; Czubala M; Ferris RG; Koppe E; Haffner C; Piguet V; Patel VK; Amrine-Madsen H; Modis LK; Masters SL; Triantafilou M
PLoS Pathog; 2021 Apr; 17(4):e1009417. PubMed ID: 33861800
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Characteristics of TIGIT-Expressing CD3
Zhang X; Lu X; Cheung AKL; Zhang Q; Liu Z; Li Z; Yuan L; Wang R; Liu Y; Tang B; Xia H; Wu H; Zhang T; Su B
Front Immunol; 2021; 12():602492. PubMed ID: 33717085
[TBL] [Abstract][Full Text] [Related]
17. Dual Antiretroviral Therapy-All Quiet Beneath the Surface?
van Welzen BJ; Oomen PGA; Hoepelman AIM
Front Immunol; 2021; 12():637910. PubMed ID: 33643320
[TBL] [Abstract][Full Text] [Related]
18. The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination.
Seddiki N; Picard F; Dupaty L; Lévy Y; Godot V
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32726934
[TBL] [Abstract][Full Text] [Related]
19. Brief Report: Markers of Spontaneous Preterm Delivery in Women Living With HIV: Relationship With Protease Inhibitors and Vitamin D.
Weinberg A; Huo Y; Kacanek D; Patel K; Watts DH; Wara D; Hoffman RM; Klawitter J; Christians U;
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):181-187. PubMed ID: 31513074
[TBL] [Abstract][Full Text] [Related]
20. Influence of Hepatitis C virus coinfection on immune reconstitution in HIV subjects.
Badano MN; Parodi C; Aloisi N; Corti M; Elizalde de Bracco MM; Baré P
Med Microbiol Immunol; 2019 Dec; 208(6):747-756. PubMed ID: 31147782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
